Literature DB >> 17164674

The Glenn A. Fry award lecture 2005. The pathogenesis of contact lens-related keratitis.

Suzanne M J Fleiszig1.   

Abstract

Bacterial infection of the cornea is a rare, but sight-threatening, complication of contact lens wear that was first reported shortly after soft lenses were introduced onto the market in the 1970s. During the past 3 decades, various attempts to solve the problem with new lens types and lens care products have failed to make a significant impact on its incidence. Eliminating contact lens-related infections will likely require a better understanding of the ocular defense system, microbial virulence strategies, how they affect one another, and the effects of contact lens wear on both. Each of these topics is complex. Although research in this area is therefore challenging and necessitates a multidisciplinary approach, what we are learning along the way has significance beyond contact lens-related infection and could ultimately lead to the development of new strategies to prevent this and a range of other sight- and life-threatening diseases.

Entities:  

Mesh:

Year:  2006        PMID: 17164674     DOI: 10.1097/01.opx.0000250045.85499.55

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  19 in total

1.  Risk factors for corneal infiltrative events during continuous wear of silicone hydrogel contact lenses.

Authors:  Loretta Szczotka-Flynn; Jonathan H Lass; Ajay Sethi; Sara Debanne; Beth Ann Benetz; Matthew Albright; Beth Gillespie; Jana Kuo; Michael R Jacobs; Alfred Rimm
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

Review 2.  Pathogenesis of contact lens-associated microbial keratitis.

Authors:  Suzanne M J Fleiszig; David J Evans
Journal:  Optom Vis Sci       Date:  2010-04       Impact factor: 1.973

3.  Innovative Cold Atmospheric Plasma (iCAP) Decreases Mucopurulent Corneal Ulcer Formation and Edema and Reduces Bacterial Load in Pseudomonas Keratitis.

Authors:  Wahaj Saleem; Angela H Benton; Mary E Marquart; Shuli Wang; Waqas Saleem; Randy Vigil; Bo Huang; Anjal C Sharma
Journal:  Clin Plasma Med       Date:  2019-12-27

Review 4.  Dry eye disease and microbial keratitis: is there a connection?

Authors:  Srihari Narayanan; Rachel L Redfern; William L Miller; Kelly K Nichols; Alison M McDermott
Journal:  Ocul Surf       Date:  2013-01-29       Impact factor: 5.033

5.  Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis.

Authors:  Mihaela Gadjeva; Jill Nagashima; Tanweer Zaidi; Robert A Mitchell; Gerald B Pier
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

6.  Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis.

Authors:  Tanweer S Zaidi; Tauqeer Zaidi; Gerald B Pier
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

7.  Role of the corneal epithelial basement membrane in ocular defense against Pseudomonas aeruginosa.

Authors:  Irania Alarcon; Lesley Kwan; Chong Yu; David J Evans; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2009-06-08       Impact factor: 3.441

8.  Staphylococcus aureus lipoproteins trigger human corneal epithelial innate response through toll-like receptor-2.

Authors:  Qiong Li; Ashok Kumar; Jian-Fang Gui; Fu-Shin X Yu
Journal:  Microb Pathog       Date:  2007-11-28       Impact factor: 3.738

Review 9.  Contact lens-related corneal infection: Intrinsic resistance and its compromise.

Authors:  Suzanne M J Fleiszig; Abby R Kroken; Vincent Nieto; Melinda R Grosser; Stephanie J Wan; Matteo M E Metruccio; David J Evans
Journal:  Prog Retin Eye Res       Date:  2019-11-20       Impact factor: 21.198

10.  Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis.

Authors:  Tanweer Zaidi; Milan Bajmoczi; Tauqeer Zaidi; David E Golan; Gerald B Pier
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.